HR in men: 0.68, 95% CI 0.530.87, p = 0.0021 for cerebrovascular, 0.65, 95% CI 0.490.88, p = 0.0051 for coronary and 0.68 95% CI 0.560.83, p = 0.00014 for MACE
The US Food and Drug Administration (FDA) has approved an additional indication for the weight loss drug semaglutidemarketed as Wegovy (Novo Nordisk) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity
The observed value was significantly greater compared to the findings reported in the previous study [34]
doi: 10.1016/j.regpep.2012.08.009 21 CamilleriMVazquez-RoqueMIturrinoJBoldinghABurtonDMcKinzieSet al
Harahap et al., 2024
These key glp 1 ingredients work together to calm digestive processes, improve efficiency, and enhance the absorption of essential nutrients from your meals